speb/financial-data huggingface dataset:
BODI cash_flow (annual, 2021-12-31) — Deferred Tax: -15862000.00
BODI cash_flow (annual, 2021-12-31) — Income Tax Paid Supplemental Data: 385000.00
BODI cash_flow (annual, 2021-12-31) — Interest Paid Supplemental Data: 466000.00
BODI cash_flow (annual, 2021-12-31) — Net Business Purchase And Sale: -37280000.00
BODI cash_flow (annual, 2021-12-31) — Net Investment Purchase And Sale: -10000000.00
BODI cash_flow (annual, 2021-12-31) — Net Short Term Debt Issuance: 0.00
BODI balance_sheet (annual, 2021-12-31) — Non Current Deferred Liabilities: 3165000.00
BODI balance_sheet (annual, 2021-12-31) — Non Current Deferred Taxes Liabilities: 3165000.00
BODI balance_sheet (annual, 2021-12-31) — Other Intangible Assets: 46367000.00
BODI cash_flow (annual, 2021-12-31) — Purchase Of Business: -37280000.00
BODI cash_flow (annual, 2021-12-31) — Purchase Of Investment: -10000000.00
BODI cash_flow (annual, 2021-12-31) — Short Term Debt Issuance: 42000000.00
BODI cash_flow (annual, 2021-12-31) — Short Term Debt Payments: -42000000.00
BODI income_statement (annual, 2022-12-31) — +Operating Expense: 542776000.00
BODI income_statement (annual, 2022-12-31) — +Total Revenue: 692199000.00
BODI balance_sheet (annual, 2022-12-31) — Accounts Payable: 17940000.00
BODI balance_sheet (annual, 2022-12-31) — Accounts Receivable: 866000.00
BODI balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -202753000.00
BODI balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 630738000.00
BODI cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 24276000.00
BODI cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 24276000.00
BODI cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 19907000.00
BODI income_statement (annual, 2022-12-31) — Basic Average Shares: 6149780.00
BODI income_statement (annual, 2022-12-31) — Basic EPS: -31.50
BODI cash_flow (annual, 2022-12-31) — Beginning Cash Position: 107054000.00
BODI balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 5158000.00
BODI cash_flow (annual, 2022-12-31) — Capital Expenditure: -26493000.00
BODI balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 5468000.00
BODI balance_sheet (annual, 2022-12-31) — Capital Stock: 2000.00
BODI balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 80091000.00
BODI balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 80091000.00
BODI cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 47561000.00
BODI cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -26493000.00
BODI cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -47173000.00
BODI cash_flow (annual, 2022-12-31) — Change In Account Payable: -26705000.00
BODI cash_flow (annual, 2022-12-31) — Change In Accrued Expense: -8673000.00
BODI cash_flow (annual, 2022-12-31) — Change In Inventory: 41510000.00
BODI cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -15546000.00
BODI cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -4593000.00
BODI cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -9563000.00
BODI cash_flow (annual, 2022-12-31) — Change In Payable: -26705000.00
BODI cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -35378000.00
BODI cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: 2806000.00
BODI cash_flow (annual, 2022-12-31) — Change In Working Capital: -20764000.00
BODI cash_flow (annual, 2022-12-31) — Changes In Cash: -26105000.00
BODI balance_sheet (annual, 2022-12-31) — Common Stock: 2000.00
BODI balance_sheet (annual, 2022-12-31) — Common Stock Equity: 211542000.00
BODI cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
BODI income_statement (annual, 2022-12-31) — Cost Of Revenue: 322626000.00
BODI balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 39028000.00
BODI balance_sheet (annual, 2022-12-31) — Current Assets: 186454000.00
BODI balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 2150000.00
BODI balance_sheet (annual, 2022-12-31) — Current Debt: 1250000.00
BODI balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 3400000.00
BODI balance_sheet (annual, 2022-12-31) — Current Deferred Assets: 31270000.00
BODI balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 95587000.00
BODI balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 95587000.00
BODI balance_sheet (annual, 2022-12-31) — Current Liabilities: 184640000.00
BODI cash_flow (annual, 2022-12-31) — Deferred Income Tax: -2961000.00
BODI cash_flow (annual, 2022-12-31) — Deferred Tax: -2961000.00
BODI cash_flow (annual, 2022-12-31) — Depreciation: 74848000.00
BODI cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 99124000.00
BODI cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 99124000.00
BODI income_statement (annual, 2022-12-31) — Diluted Average Shares: 6149780.00
BODI income_statement (annual, 2022-12-31) — Diluted EPS: -31.50
BODI income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -194192000.00
BODI income_statement (annual, 2022-12-31) — EBIT: -193877000.00
BODI income_statement (annual, 2022-12-31) — EBITDA: -94753000.00
BODI cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -858000.00
BODI cash_flow (annual, 2022-12-31) — End Cash Position: 80091000.00
BODI cash_flow (annual, 2022-12-31) — Financing Cash Flow: 47561000.00
BODI balance_sheet (annual, 2022-12-31) — Finished Goods: 40680000.00
BODI cash_flow (annual, 2022-12-31) — Free Cash Flow: -73666000.00
BODI cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: -8214000.00
BODI income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 8322000.00
BODI balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: 37000.00
BODI income_statement (annual, 2022-12-31) — General And Administrative Expense: 78426000.00
BODI balance_sheet (annual, 2022-12-31) — Goodwill: 125166000.00
BODI balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 133370000.00
BODI balance_sheet (annual, 2022-12-31) — Gross PPE: 281930000.00
BODI income_statement (annual, 2022-12-31) — Gross Profit: 369573000.00
BODI income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 19907000.00
BODI cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 389000.00
BODI income_statement (annual, 2022-12-31) — Interest Expense: 3368000.00
BODI income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 3368000.00
BODI cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 2082000.00
BODI balance_sheet (annual, 2022-12-31) — Inventory: 54060000.00
BODI balance_sheet (annual, 2022-12-31) — Invested Capital: 252527000.00
BODI cash_flow (annual, 2022-12-31) — Investing Cash Flow: -26493000.00
BODI cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
BODI cash_flow (annual, 2022-12-31) — Issuance Of Debt: 50000000.00
BODI balance_sheet (annual, 2022-12-31) — Leases: 4600000.00
BODI balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 3318000.00
BODI balance_sheet (annual, 2022-12-31) — Long Term Debt: 39735000.00
BODI balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 43053000.00
BODI cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 50000000.00
BODI cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -625000.00
BODI balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 267142000.00
BODI cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 0.00
BODI cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 0.00
BODI income_statement (annual, 2022-12-31) — Net Income: -194192000.00
BODI income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -194192000.00
BODI income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -194192000.00
BODI income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -194192000.00
BODI income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -194192000.00
BODI cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -194192000.00
BODI income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -194192000.00
BODI income_statement (annual, 2022-12-31) — Net Interest Income: -3368000.00
BODI cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 0.00
BODI cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 49375000.00
BODI cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 49375000.00
BODI income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -3368000.00
BODI cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -4976000.00
BODI balance_sheet (annual, 2022-12-31) — Net PPE: 79177000.00
BODI cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -26493000.00
BODI balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 78172000.00
BODI balance_sheet (annual, 2022-12-31) — Non Current Accounts Receivable: 34888000.00
BODI balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 181000.00
BODI balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 181000.00
BODI income_statement (annual, 2022-12-31) — Normalized EBITDA: -73121000.00
BODI income_statement (annual, 2022-12-31) — Normalized Income: -172884480.00
BODI cash_flow (annual, 2022-12-31) — Operating Cash Flow: -47173000.00
BODI cash_flow (annual, 2022-12-31) — Operating Gains Losses: -8214000.00
BODI income_statement (annual, 2022-12-31) — Operating Income: -173203000.00
BODI income_statement (annual, 2022-12-31) — Operating Revenue: 692199000.00
BODI balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 6243242.00
BODI balance_sheet (annual, 2022-12-31) — Other Current Assets: 2585000.00
BODI balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 1250000.00
BODI balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 3283000.00
BODI balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: 37000.00
BODI income_statement (annual, 2022-12-31) — Other Gand A: 78426000.00
BODI income_statement (annual, 2022-12-31) — Other Income Expense: -20674000.00
BODI balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 8204000.00
BODI cash_flow (annual, 2022-12-31) — Other Non Cash Items: 2550000.00
BODI balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 9506000.00
BODI balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 3979000.00
BODI income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 958000.00
BODI balance_sheet (annual, 2022-12-31) — Other Properties: 5030000.00
BODI balance_sheet (annual, 2022-12-31) — Payables: 22758000.00
BODI balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 61786000.00
BODI balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 20584000.00
BODI balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
BODI balance_sheet (annual, 2022-12-31) — Prepaid Assets: 17582000.00
BODI income_statement (annual, 2022-12-31) — Pretax Income: -197245000.00
BODI cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 3162000.00
BODI balance_sheet (annual, 2022-12-31) — Properties: 0.00
BODI cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: 39757000.00
BODI cash_flow (annual, 2022-12-31) — Purchase Of Business: 0.00
BODI cash_flow (annual, 2022-12-31) — Purchase Of Investment: 0.00
BODI cash_flow (annual, 2022-12-31) — Purchase Of PPE: -26493000.00
BODI balance_sheet (annual, 2022-12-31) — Raw Materials: 13380000.00
BODI balance_sheet (annual, 2022-12-31) — Receivables: 866000.00
BODI income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 322626000.00
BODI income_statement (annual, 2022-12-31) — Reconciled Depreciation: 99124000.00
BODI cash_flow (annual, 2022-12-31) — Repayment Of Debt: -625000.00
BODI income_statement (annual, 2022-12-31) — Research And Development: 104363000.00
BODI balance_sheet (annual, 2022-12-31) — Restricted Cash: 0.00
BODI income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 10047000.00
BODI balance_sheet (annual, 2022-12-31) — Retained Earnings: -419235000.00
BODI income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 359987000.00
BODI income_statement (annual, 2022-12-31) — Selling General And Administration: 438413000.00
BODI balance_sheet (annual, 2022-12-31) — Share Issued: 6243242.00
BODI income_statement (annual, 2022-12-31) — Special Income Charges: -29954000.00
BODI cash_flow (annual, 2022-12-31) — Stock Based Compensation: 17620000.00
BODI balance_sheet (annual, 2022-12-31) — Stockholders Equity: 211542000.00
BODI balance_sheet (annual, 2022-12-31) — Tangible Book Value: 78172000.00
BODI income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -324480.00
BODI income_statement (annual, 2022-12-31) — Tax Provision: -3053000.00
BODI income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.02
BODI balance_sheet (annual, 2022-12-31) — Total Assets: 443395000.00
BODI balance_sheet (annual, 2022-12-31) — Total Capitalization: 251277000.00
BODI balance_sheet (annual, 2022-12-31) — Total Debt: 46453000.00
BODI balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 211542000.00
BODI income_statement (annual, 2022-12-31) — Total Expenses: 865402000.00
BODI balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 231853000.00
BODI balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 256941000.00
BODI balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 47213000.00
BODI income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -203157000.00
BODI balance_sheet (annual, 2022-12-31) — Total Tax Payable: 4818000.00
BODI income_statement (annual, 2022-12-31) — Total Unusual Items: -21632000.00
BODI income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -21632000.00
BODI balance_sheet (annual, 2022-12-31) — Working Capital: 1814000.00
BODI income_statement (annual, 2022-12-31) — Write Off: 0.00
BODI income_statement (annual, 2023-12-31) — +Operating Expense: 414486000.00
BODI income_statement (annual, 2023-12-31) — +Total Revenue: 527109000.00
BODI balance_sheet (annual, 2023-12-31) — Accounts Payable: 10659000.00
BODI balance_sheet (annual, 2023-12-31) — Accounts Receivable: 1270000.00
BODI balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -221291000.00
BODI balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 654657000.00
BODI cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 23755000.00
BODI cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 23755000.00
BODI cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 47092000.00
BODI income_statement (annual, 2023-12-31) — Basic Average Shares: 6238777.00
BODI income_statement (annual, 2023-12-31) — Basic EPS: -24.47
BODI cash_flow (annual, 2023-12-31) — Beginning Cash Position: 80091000.00
BODI balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 5158000.00
BODI cash_flow (annual, 2023-12-31) — Capital Expenditure: -6576000.00
BODI balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 3260000.00
BODI balance_sheet (annual, 2023-12-31) — Capital Stock: 2000.00
BODI balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 33309000.00
BODI balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 33309000.00
BODI cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -13717000.00
BODI cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -10826000.00
BODI cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -22537000.00
BODI cash_flow (annual, 2023-12-31) — Change In Account Payable: -7103000.00
BODI cash_flow (annual, 2023-12-31) — Change In Accrued Expense: -20293000.00
BODI cash_flow (annual, 2023-12-31) — Change In Inventory: 17508000.00
BODI cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -14664000.00
BODI cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -415000.00
BODI cash_flow (annual, 2023-12-31) — Change In Other Working Capital: 2163000.00
BODI cash_flow (annual, 2023-12-31) — Change In Payable: -7103000.00
BODI cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -27396000.00
BODI cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 2340000.00
BODI cash_flow (annual, 2023-12-31) — Change In Working Capital: -20464000.00
BODI cash_flow (annual, 2023-12-31) — Changes In Cash: -47080000.00
BODI balance_sheet (annual, 2023-12-31) — Common Stock: 2000.00
BODI balance_sheet (annual, 2023-12-31) — Common Stock Equity: 82760000.00
BODI cash_flow (annual, 2023-12-31) — Common Stock Issuance: 4908000.00
BODI income_statement (annual, 2023-12-31) — Cost Of Revenue: 204022000.00
BODI balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 33850000.00
BODI balance_sheet (annual, 2023-12-31) — Current Assets: 119273000.00
BODI balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 1835000.00
BODI balance_sheet (annual, 2023-12-31) — Current Debt: 8068000.00
BODI balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 9903000.00
BODI balance_sheet (annual, 2023-12-31) — Current Deferred Assets: 36169000.00
BODI balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 97169000.00
BODI balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 97169000.00
BODI balance_sheet (annual, 2023-12-31) — Current Liabilities: 165203000.00
BODI cash_flow (annual, 2023-12-31) — Deferred Income Tax: -191000.00
BODI cash_flow (annual, 2023-12-31) — Deferred Tax: -191000.00
BODI cash_flow (annual, 2023-12-31) — Depreciation: 39573000.00
BODI cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 63328000.00
BODI cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 63328000.00
BODI income_statement (annual, 2023-12-31) — Diluted Average Shares: 6238777.00
BODI income_statement (annual, 2023-12-31) — Diluted EPS: -24.47
BODI income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -152641000.00
BODI income_statement (annual, 2023-12-31) — EBIT: -143730000.00
BODI income_statement (annual, 2023-12-31) — EBITDA: -80402000.00
BODI cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 398000.00
BODI cash_flow (annual, 2023-12-31) — End Cash Position: 33409000.00
BODI cash_flow (annual, 2023-12-31) — Financing Cash Flow: -13717000.00
BODI balance_sheet (annual, 2023-12-31) — Finished Goods: 14622000.00
BODI cash_flow (annual, 2023-12-31) — Free Cash Flow: -29113000.00
BODI cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: -2457000.00
BODI cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 0.00
BODI income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 2679000.00
BODI balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -23000.00
BODI income_statement (annual, 2023-12-31) — General And Administrative Expense: 57932000.00
BODI balance_sheet (annual, 2023-12-31) — Goodwill: 85166000.00
BODI balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 85166000.00
BODI balance_sheet (annual, 2023-12-31) — Gross PPE: 269409000.00
BODI income_statement (annual, 2023-12-31) — Gross Profit: 323087000.00
BODI income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 43092000.00
BODI cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 11000.00
BODI income_statement (annual, 2023-12-31) — Interest Expense: 8874000.00
BODI income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 8874000.00
BODI cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 5389000.00
BODI balance_sheet (annual, 2023-12-31) — Inventory: 24976000.00
BODI balance_sheet (annual, 2023-12-31) — Invested Capital: 112319000.00
BODI cash_flow (annual, 2023-12-31) — Investing Cash Flow: -10826000.00
BODI cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 4908000.00
BODI cash_flow (annual, 2023-12-31) — Issuance Of Debt: 0.00
BODI balance_sheet (annual, 2023-12-31) — Leases: 4600000.00
BODI balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 1425000.00
BODI balance_sheet (annual, 2023-12-31) — Long Term Debt: 21491000.00
BODI balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 22916000.00
BODI cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 0.00
BODI cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -17000000.00
BODI balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 256588000.00
BODI cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 4908000.00
BODI income_statement (annual, 2023-12-31) — Net Income: -152641000.00
BODI income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -152641000.00
BODI income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -152641000.00
BODI income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -152641000.00
BODI income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -152641000.00
BODI cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -152641000.00
BODI income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -152641000.00
BODI income_statement (annual, 2023-12-31) — Net Interest Income: -8874000.00
BODI cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -17000000.00
BODI cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -17000000.00
BODI income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -8874000.00
BODI cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -2178000.00
BODI cash_flow (annual, 2023-12-31) — Net Other Investing Changes: -4250000.00
BODI balance_sheet (annual, 2023-12-31) — Net PPE: 48118000.00
BODI cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -6576000.00
BODI balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -2406000.00
BODI balance_sheet (annual, 2023-12-31) — Non Current Accounts Receivable: 21359000.00
BODI balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 10000.00
BODI balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 10000.00
BODI income_statement (annual, 2023-12-31) — Normalized EBITDA: -26324000.00
BODI income_statement (annual, 2023-12-31) — Normalized Income: -98563000.00
BODI cash_flow (annual, 2023-12-31) — Operating Cash Flow: -22537000.00
BODI cash_flow (annual, 2023-12-31) — Operating Gains Losses: 711000.00
BODI income_statement (annual, 2023-12-31) — Operating Income: -91399000.00
BODI income_statement (annual, 2023-12-31) — Operating Revenue: 527109000.00
BODI balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 6707359.00
BODI balance_sheet (annual, 2023-12-31) — Other Current Assets: 1696000.00
BODI balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 8068000.00
BODI balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 5325000.00
BODI balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -23000.00
BODI income_statement (annual, 2023-12-31) — Other Gand A: 57932000.00
BODI income_statement (annual, 2023-12-31) — Other Income Expense: -52331000.00
BODI cash_flow (annual, 2023-12-31) — Other Non Cash Items: 5176000.00
BODI balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 2923000.00
BODI balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 5950000.00
BODI income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 1747000.00
BODI balance_sheet (annual, 2023-12-31) — Other Properties: 3063000.00
BODI income_statement (annual, 2023-12-31) — Other Special Charges: 3168000.00
BODI balance_sheet (annual, 2023-12-31) — Payables: 14622000.00
BODI balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 48472000.00
BODI balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 4334000.00
BODI balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
BODI balance_sheet (annual, 2023-12-31) — Prepaid Assets: 17503000.00
BODI income_statement (annual, 2023-12-31) — Pretax Income: -152604000.00
BODI cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 553000.00
BODI balance_sheet (annual, 2023-12-31) — Properties: 0.00
BODI cash_flow (annual, 2023-12-31) — Provisionand Write Offof Assets: 10561000.00
BODI cash_flow (annual, 2023-12-31) — Purchase Of PPE: -6576000.00
BODI balance_sheet (annual, 2023-12-31) — Raw Materials: 10354000.00
BODI balance_sheet (annual, 2023-12-31) — Receivables: 1270000.00
BODI income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 204022000.00
BODI income_statement (annual, 2023-12-31) — Reconciled Depreciation: 63328000.00
BODI cash_flow (annual, 2023-12-31) — Repayment Of Debt: -17000000.00
BODI income_statement (annual, 2023-12-31) — Research And Development: 74407000.00
BODI balance_sheet (annual, 2023-12-31) — Restricted Cash: 4350000.00
BODI income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 6497000.00
BODI balance_sheet (annual, 2023-12-31) — Retained Earnings: -571876000.00
BODI cash_flow (annual, 2023-12-31) — Sale Of PPE: 0.00
BODI income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 282147000.00
BODI income_statement (annual, 2023-12-31) — Selling General And Administration: 340079000.00
BODI balance_sheet (annual, 2023-12-31) — Share Issued: 6707359.00
BODI income_statement (annual, 2023-12-31) — Special Income Charges: -56757000.00
BODI cash_flow (annual, 2023-12-31) — Stock Based Compensation: 23891000.00
BODI balance_sheet (annual, 2023-12-31) — Stockholders Equity: 82760000.00
BODI balance_sheet (annual, 2023-12-31) — Tangible Book Value: -2406000.00
BODI income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
BODI income_statement (annual, 2023-12-31) — Tax Provision: 37000.00
BODI income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
BODI balance_sheet (annual, 2023-12-31) — Total Assets: 276839000.00
BODI balance_sheet (annual, 2023-12-31) — Total Capitalization: 104251000.00
BODI balance_sheet (annual, 2023-12-31) — Total Debt: 32819000.00
BODI balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 82760000.00
BODI income_statement (annual, 2023-12-31) — Total Expenses: 618508000.00
BODI balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 194079000.00
BODI balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 157566000.00
BODI balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 28876000.00
BODI income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -140988000.00
BODI balance_sheet (annual, 2023-12-31) — Total Tax Payable: 3963000.00
BODI income_statement (annual, 2023-12-31) — Total Unusual Items: -54078000.00
BODI income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -54078000.00
BODI balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
BODI balance_sheet (annual, 2023-12-31) — Working Capital: -45930000.00
BODI income_statement (annual, 2023-12-31) — Write Off: 4000000.00
BODI balance_sheet (quarterly, 2024-09-30) — Buildings And Improvements: 0.00
BODI cash_flow (quarterly, 2024-09-30) — Deferred Income Tax: 1000.00
BODI cash_flow (quarterly, 2024-09-30) — Deferred Tax: 1000.00
BODI cash_flow (quarterly, 2024-09-30) — Income Tax Paid Supplemental Data: 40000.00
BODI cash_flow (quarterly, 2024-09-30) — Interest Paid Supplemental Data: 820000.00
BODI cash_flow (quarterly, 2024-09-30) — Issuance Of Debt: 0.00
BODI cash_flow (quarterly, 2024-09-30) — Long Term Debt Issuance: 0.00
BODI balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Liabilities: 0.00
BODI balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 0.00
BODI balance_sheet (quarterly, 2024-09-30) — Other Intangible Assets: 14498000.00
BODI income_statement (annual, 2024-12-31) — +Operating Expense: 325705000.00
BODI income_statement (annual, 2024-12-31) — +Total Revenue: 418796000.00
BODI balance_sheet (annual, 2024-12-31) — Accounts Payable: 9534000.00
BODI balance_sheet (annual, 2024-12-31) — Accounts Receivable: 1449000.00
BODI balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -129148000.00
BODI balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 671735000.00
BODI cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 15667000.00
BODI cash_flow (annual, 2024-12-31) — Amortization Of Intangibles: 15667000.00
BODI cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 20000000.00
BODI income_statement (annual, 2024-12-31) — Basic Average Shares: 6818000.00
BODI income_statement (annual, 2024-12-31) — Basic EPS: -10.51
BODI cash_flow (annual, 2024-12-31) — Beginning Cash Position: 33409000.00
BODI balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 0.00
BODI balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 0.00
BODI cash_flow (annual, 2024-12-31) — Capital Expenditure: -4542000.00
BODI balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 3311000.00
BODI balance_sheet (annual, 2024-12-31) — Capital Stock: 2000.00
BODI balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 20087000.00
BODI balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 20087000.00
BODI cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -15868000.00
BODI cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: 1058000.00
BODI cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 2562000.00
BODI cash_flow (annual, 2024-12-31) — Change In Account Payable: -906000.00
BODI cash_flow (annual, 2024-12-31) — Change In Accrued Expense: -16570000.00
BODI cash_flow (annual, 2024-12-31) — Change In Inventory: 4376000.00
BODI cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 10750000.00
BODI cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -626000.00
BODI cash_flow (annual, 2024-12-31) — Change In Other Working Capital: -16693000.00
BODI cash_flow (annual, 2024-12-31) — Change In Payable: -906000.00
BODI cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -17476000.00
BODI cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 1681000.00
BODI cash_flow (annual, 2024-12-31) — Change In Working Capital: -17988000.00
BODI cash_flow (annual, 2024-12-31) — Changes In Cash: -12248000.00
BODI balance_sheet (annual, 2024-12-31) — Common Stock: 2000.00
BODI balance_sheet (annual, 2024-12-31) — Common Stock Equity: 28170000.00
BODI cash_flow (annual, 2024-12-31) — Common Stock Issuance: 0.00
BODI income_statement (annual, 2024-12-31) — Cost Of Revenue: 131452000.00
BODI balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 16677000.00
BODI balance_sheet (annual, 2024-12-31) — Current Assets: 78685000.00
BODI balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 1338000.00
BODI balance_sheet (annual, 2024-12-31) — Current Debt: 9500000.00
BODI balance_sheet (quarterly, 2024-12-31) — Current Debt: 9500000.00
BODI balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 10838000.00
BODI balance_sheet (annual, 2024-12-31) — Current Deferred Assets: 25730000.00
BODI balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 77273000.00
BODI balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 77273000.00
BODI balance_sheet (annual, 2024-12-31) — Current Liabilities: 127638000.00
BODI cash_flow (annual, 2024-12-31) — Deferred Income Tax: 5000.00
BODI cash_flow (quarterly, 2024-12-31) — Deferred Income Tax: 3000.00
BODI cash_flow (annual, 2024-12-31) — Deferred Tax: 5000.00
BODI cash_flow (quarterly, 2024-12-31) — Deferred Tax: 3000.00
BODI cash_flow (annual, 2024-12-31) — Depreciation: 31439000.00
BODI cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 47106000.00
BODI cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 47106000.00
BODI income_statement (annual, 2024-12-31) — Diluted Average Shares: 6818000.00
BODI income_statement (annual, 2024-12-31) — Diluted EPS: -10.51
BODI income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -71642000.00
BODI income_statement (annual, 2024-12-31) — EBIT: -64521000.00
BODI income_statement (annual, 2024-12-31) — EBITDA: -17415000.00
BODI cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -974000.00
BODI cash_flow (annual, 2024-12-31) — End Cash Position: 20187000.00
BODI cash_flow (annual, 2024-12-31) — Financing Cash Flow: -15868000.00
BODI balance_sheet (annual, 2024-12-31) — Finished Goods: 8653000.00
BODI cash_flow (annual, 2024-12-31) — Free Cash Flow: -1980000.00
BODI cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: -1080000.00
BODI cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: -784000.00
BODI cash_flow (quarterly, 2024-12-31) — Gain Loss On Sale Of PPE: 0.00
BODI income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 1144000.00
BODI balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -49000.00
BODI income_statement (annual, 2024-12-31) — General And Administrative Expense: 49190000.00
BODI balance_sheet (annual, 2024-12-31) — Goodwill: 65166000.00
BODI balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 65166000.00
BODI balance_sheet (annual, 2024-12-31) — Gross PPE: 144960000.00
BODI income_statement (annual, 2024-12-31) — Gross Profit: 287344000.00
BODI income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 20000000.00
BODI income_statement (annual, 2024-12-31) — Interest Expense: 6882000.00
BODI income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 6882000.00
BODI balance_sheet (annual, 2024-12-31) — Inventory: 16303000.00
BODI balance_sheet (annual, 2024-12-31) — Invested Capital: 47338000.00
BODI cash_flow (annual, 2024-12-31) — Investing Cash Flow: 1058000.00
BODI cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 0.00
BODI cash_flow (annual, 2024-12-31) — Issuance Of Debt: 0.00
BODI balance_sheet (annual, 2024-12-31) — Leases: 1117000.00
BODI balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 1973000.00
BODI balance_sheet (annual, 2024-12-31) — Long Term Debt: 9668000.00
BODI balance_sheet (quarterly, 2024-12-31) — Long Term Debt: 9668000.00
BODI balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 11641000.00
BODI cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 0.00
BODI cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -15877000.00
BODI balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 140780000.00
BODI cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 0.00
BODI income_statement (annual, 2024-12-31) — Net Income: -71642000.00
BODI income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -71642000.00
BODI income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -71642000.00
BODI income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -71642000.00
BODI income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -71642000.00
BODI cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -71642000.00
BODI income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -71642000.00
BODI income_statement (annual, 2024-12-31) — Net Interest Income: -6882000.00
BODI cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -15877000.00
BODI cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -15877000.00
BODI income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -6882000.00
BODI cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -263000.00
BODI balance_sheet (annual, 2024-12-31) — Net PPE: 15812000.00
BODI cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: 1058000.00
BODI balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -36996000.00
BODI balance_sheet (annual, 2024-12-31) — Non Current Accounts Receivable: 12179000.00
BODI balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 1000.00
BODI balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Liabilities: 1000.00
BODI balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 1000.00
BODI balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Liabilities: 1000.00
BODI income_statement (annual, 2024-12-31) — Normalized EBITDA: 11667000.00
BODI income_statement (annual, 2024-12-31) — Normalized Income: -48667220.00
BODI cash_flow (annual, 2024-12-31) — Operating Cash Flow: 2562000.00
BODI cash_flow (annual, 2024-12-31) — Operating Gains Losses: 515000.00
BODI income_statement (annual, 2024-12-31) — Operating Income: -38361000.00
BODI income_statement (annual, 2024-12-31) — Operating Revenue: 418796000.00
BODI balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 6947831.00
BODI balance_sheet (annual, 2024-12-31) — Other Current Assets: 1732000.00
BODI balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 9500000.00
BODI balance_sheet (quarterly, 2024-12-31) — Other Current Borrowings: 9500000.00
BODI balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 5011000.00
BODI balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -49000.00
BODI income_statement (annual, 2024-12-31) — Other Gand A: 49190000.00
BODI income_statement (annual, 2024-12-31) — Other Income Expense: -26160000.00
BODI cash_flow (annual, 2024-12-31) — Other Non Cash Items: 3298000.00
BODI balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 2714000.00
BODI balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 7107000.00
BODI income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 2922000.00
BODI balance_sheet (annual, 2024-12-31) — Other Properties: 3063000.00
BODI income_statement (annual, 2024-12-31) — Other Special Charges: 2379000.00
BODI income_statement (quarterly, 2024-12-31) — Other Special Charges: 451000.00
BODI balance_sheet (annual, 2024-12-31) — Payables: 12659000.00
BODI balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 29336000.00
BODI balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 5180000.00
BODI balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
BODI balance_sheet (annual, 2024-12-31) — Prepaid Assets: 9034000.00
BODI income_statement (annual, 2024-12-31) — Pretax Income: -71403000.00
BODI cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 272000.00
BODI balance_sheet (annual, 2024-12-31) — Properties: 0.00
BODI cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: 4204000.00
BODI cash_flow (annual, 2024-12-31) — Purchase Of PPE: -4542000.00
BODI balance_sheet (annual, 2024-12-31) — Raw Materials: 7650000.00
BODI balance_sheet (annual, 2024-12-31) — Receivables: 1449000.00
BODI income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 131452000.00
BODI income_statement (annual, 2024-12-31) — Reconciled Depreciation: 47106000.00
BODI cash_flow (annual, 2024-12-31) — Repayment Of Debt: -15877000.00
BODI income_statement (annual, 2024-12-31) — Research And Development: 76370000.00
BODI balance_sheet (annual, 2024-12-31) — Restricted Cash: 4350000.00
BODI income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 7847000.00
BODI income_statement (quarterly, 2024-12-31) — Restructuring And Mergern Acquisition: 1116000.00
BODI balance_sheet (annual, 2024-12-31) — Retained Earnings: -643518000.00
BODI cash_flow (annual, 2024-12-31) — Sale Of PPE: 5600000.00
BODI cash_flow (quarterly, 2024-12-31) — Sale Of PPE: 0.00
BODI income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 200145000.00
BODI income_statement (annual, 2024-12-31) — Selling General And Administration: 249335000.00
BODI balance_sheet (annual, 2024-12-31) — Share Issued: 6947831.00
BODI income_statement (annual, 2024-12-31) — Special Income Charges: -30226000.00
BODI income_statement (quarterly, 2024-12-31) — Special Income Charges: -21567000.00
BODI cash_flow (annual, 2024-12-31) — Stock Based Compensation: 17069000.00
BODI balance_sheet (annual, 2024-12-31) — Stockholders Equity: 28170000.00
BODI balance_sheet (annual, 2024-12-31) — Tangible Book Value: -36996000.00
BODI income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -6107220.00
BODI income_statement (annual, 2024-12-31) — Tax Provision: 239000.00
BODI income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
BODI balance_sheet (annual, 2024-12-31) — Total Assets: 174556000.00
BODI balance_sheet (annual, 2024-12-31) — Total Capitalization: 37838000.00
BODI balance_sheet (annual, 2024-12-31) — Total Debt: 22479000.00
BODI balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 28170000.00
BODI income_statement (annual, 2024-12-31) — Total Expenses: 457157000.00
BODI balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 146386000.00
BODI balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 95871000.00
BODI balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 18748000.00
BODI income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -66208000.00
BODI balance_sheet (annual, 2024-12-31) — Total Tax Payable: 3125000.00
BODI income_statement (annual, 2024-12-31) — Total Unusual Items: -29082000.00
BODI income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -29082000.00
BODI balance_sheet (annual, 2024-12-31) — Working Capital: -48953000.00
BODI income_statement (annual, 2024-12-31) — Write Off: 0.00
BODI income_statement (quarterly, 2025-03-31) — +Operating Expense: 55223000.00
BODI income_statement (quarterly, 2025-03-31) — +Total Revenue: 72363000.00
BODI balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 8173000.00
BODI balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 1933000.00
BODI balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -130157000.00
BODI balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 673357000.00
BODI cash_flow (quarterly, 2025-03-31) — Amortization Cash Flow: 2729000.00
BODI cash_flow (quarterly, 2025-03-31) — Amortization Of Intangibles: 2729000.00
BODI income_statement (quarterly, 2025-03-31) — Basic Average Shares: 6883000.00
BODI income_statement (quarterly, 2025-03-31) — Basic EPS: -0.84
BODI cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 20187000.00
BODI cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -694000.00
BODI balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 3027000.00
BODI balance_sheet (quarterly, 2025-03-31) — Capital Stock: 2000.00
BODI balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 18026000.00
BODI balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 18026000.00
BODI cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -3729000.00
BODI cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -694000.00
BODI cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 2342000.00
BODI cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -1310000.00
BODI cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -5597000.00
BODI cash_flow (quarterly, 2025-03-31) — Change In Inventory: 2677000.00
BODI cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 10297000.00
BODI cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -1794000.00
BODI cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -7369000.00
BODI cash_flow (quarterly, 2025-03-31) — Change In Payable: -1310000.00
BODI cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -6907000.00
BODI cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 1867000.00
BODI cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -1229000.00
BODI cash_flow (quarterly, 2025-03-31) — Changes In Cash: -2081000.00
BODI balance_sheet (quarterly, 2025-03-31) — Common Stock: 2000.00
BODI balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 24035000.00
BODI income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 20814000.00
BODI balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 11966000.00
BODI balance_sheet (quarterly, 2025-03-31) — Current Assets: 61658000.00
BODI balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 1352000.00
BODI balance_sheet (quarterly, 2025-03-31) — Current Debt: 16425000.00
BODI balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 17777000.00
BODI balance_sheet (quarterly, 2025-03-31) — Current Deferred Assets: 14963000.00
BODI balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 69819000.00
BODI balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 69819000.00
BODI balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 118844000.00
BODI cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 0.00
BODI cash_flow (quarterly, 2025-03-31) — Deferred Tax: 0.00
BODI cash_flow (quarterly, 2025-03-31) — Depreciation: 2888000.00
BODI cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 5617000.00
BODI cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 5617000.00
BODI income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 6883000.00
BODI income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.84
BODI income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -5748000.00
BODI income_statement (quarterly, 2025-03-31) — EBIT: -4138000.00
BODI income_statement (quarterly, 2025-03-31) — EBITDA: 1479000.00
BODI cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 20000.00
BODI cash_flow (quarterly, 2025-03-31) — End Cash Position: 18126000.00
BODI cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -3729000.00
BODI balance_sheet (quarterly, 2025-03-31) — Finished Goods: 7059000.00
BODI cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 1648000.00
BODI cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: 689000.00
BODI cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of PPE: 0.00
BODI income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -689000.00
BODI balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -58000.00
BODI income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 11657000.00
BODI balance_sheet (quarterly, 2025-03-31) — Goodwill: 65166000.00
BODI balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 65166000.00
BODI balance_sheet (quarterly, 2025-03-31) — Gross PPE: 143622000.00
BODI income_statement (quarterly, 2025-03-31) — Gross Profit: 51549000.00
BODI cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 7000.00
BODI income_statement (quarterly, 2025-03-31) — Interest Expense: 1565000.00
BODI income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 1565000.00
BODI cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 645000.00
BODI balance_sheet (quarterly, 2025-03-31) — Inventory: 13480000.00
BODI balance_sheet (quarterly, 2025-03-31) — Invested Capital: 40460000.00
BODI cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -694000.00
BODI balance_sheet (quarterly, 2025-03-31) — Leases: 1117000.00
BODI balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 1675000.00
BODI balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 1675000.00
BODI cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -3625000.00
BODI balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 139701000.00
BODI income_statement (quarterly, 2025-03-31) — Net Income: -5748000.00
BODI income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -5748000.00